Replies to post #74879 on Biotech Values

[DewDiligence]

We already see a trend to shift the treatment paradigm from non specific immunomodulator drugs toward direct antiviral therapies in HCV.

I guess this means you agree with my analysis, by and large.

By the way, who aside from you is meant to be included in your use of the word, we? Or is that the “royal” form of we? :- )